MAP2K7 and non-small cell lung carcinoma: Recent report suggest that USP32 promotes tumor progression by activating the RAF/MEK/ERK signaling pathway and inducing epithelial-mesenchymal transition (EMT) by stabilizing BAG3 protein expression in non-small cell lung cancer 45.